Chargement en cours...
Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug
Metformin, a well-known insulin-sensitizer commonly used for type 2 diabetes therapy, has recently emerged as potentially very attractive drug also in oncology. It is cheap, it is relatively safe and many reports have indicated effects in cancer prevention and therapy. These desirable features are p...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3877110/ https://ncbi.nlm.nih.gov/pubmed/24391834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0083832 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|